|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4B
|
|
pubmed:dateCreated |
2006-8-4
|
|
pubmed:abstractText |
Caveolin-1 is an essential component of caveolae and its expression is known to be increased in human prostate cancer. The reduction of caveolin-1 expression has been reported to decrease the tumorigenic and metastatic potential of prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2977-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16886623-Caveolin 1,
pubmed-meshheading:16886623-Cell Line, Tumor,
pubmed-meshheading:16886623-Diphosphonates,
pubmed-meshheading:16886623-Dose-Response Relationship, Drug,
pubmed-meshheading:16886623-Humans,
pubmed-meshheading:16886623-Male,
pubmed-meshheading:16886623-Prostatic Neoplasms,
pubmed-meshheading:16886623-RNA, Messenger,
pubmed-meshheading:16886623-Terpenes
|
|
pubmed:articleTitle |
Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells.
|
|
pubmed:affiliation |
Laboratory of Pharmaceutics, Gifu Pharmaceutical University, Gifu, Gifu 502-8585, Japan. hirano@gifu-pu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
